Adherence Rates to Oral Antidiabetic Medications in Type 2 Diabetes Mellitus: A Systemic Review

Abstract

 Background: Medication adherence to an extent determines how effective diabetes management is. But, keeping track of oral anti-diabetic medication intake is not quite simple for patients who are suffering from Type 2 Diabetes Mellitus (T2DM). Non-adherence could bring loss of blood sugar level control and result in diabetes-related clinical and economic costs rise. Objective: This systematic article review focused on gathering together the existing evidence on medication adherence when it comes to orally taken antidiabetic drugs for T2DM patients. Besides, this research aimed at uncovering the essential factors that influence adherence, persistence and the stopping of the treatment. Methods: Published literature concerned with the issue of medication adherence, mainly in T2DM patients, has been the focus of my critical review. The paper highlights various facets of medication adherence like adherence rates persistence discontinuation plus the factors that impact the patients' drug-taking behaviour and interventions created for boosting adherence. On top of that, during our discussion of the synthesis phase, we have accounted for the variation in methods used for evaluating medication adherence, categories of treatment, characteristics of the patients and variations in the healthcare settings. Results: The results show that the extent of medication adherence to the different types of diabetic therapies varied Really among different classes and patients. In general, adherence was quite low with complex therapy plans polypharmacy side effects forgetfulness frequent dosing, economic hardship and poor diabetes knowledge as main causes of non-adherence. The authors also found a significant correlation between the use patterns and the discontinuation of different therapeutic options. The use of services led by pharmacists, including patient education, medication re-verification and the monitoring of patients in general, were also tied to a rise in the level of adherence to the medication regimen. Conclusion: Persistence with antidiabetic pills remains a big problem while managing diabetes mellitus type 2 for a long period of time. Involving a patient-centred multi-level strategy for patients' cooperation like easy access to medicines, information sharing with the patient, periodic check-ups, handling side-effects and assistance by experts, might help in getting the patient to be more cooperative with medication. Standard ways of estimating compliance have to be agreed on for making a more dependable comparison of research results.